Deferred Tax Assets, Valuation Allowance of KIORA PHARMACEUTICALS INC from 31 Dec 2014 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
KIORA PHARMACEUTICALS INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2024.
  • KIORA PHARMACEUTICALS INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $13,139,483, a 60% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

KIORA PHARMACEUTICALS INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $13,139,483 -$19,886,346 -60% 31 Dec 2024 10-K 25 Mar 2025 2024 FY
Q4 2023 $33,025,829 +$3,432,543 +12% 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q4 2022 $29,593,286 +$1,294,947 +4.6% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q4 2021 $28,298,339 +$2,978,180 +12% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q4 2020 $25,320,159 -$957,988 -3.6% 31 Dec 2020 10-K/A 07 Jul 2022 2021 FY
Q4 2019 $26,278,147 +$2,618,303 +11% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q4 2018 $23,659,844 -$415,695 -1.7% 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q4 2017 $24,075,539 -$6,824,677 -22% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q4 2016 $30,900,216 +$4,809,368 +18% 31 Dec 2016 10-K 02 Mar 2018 2017 FY
Q4 2015 $26,090,848 +$2,478,227 +10% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q4 2014 $23,612,621 31 Dec 2014 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.